Cargando…

In situ fabrication of radiopaque microcapsules for oral delivery and real-time gastrointestinal tracking of Bifidobacterium

INTRODUCTION: Although oral administration of Bifidobacterium is a promising approach for diseases, lack of resistance to harsh conditions and real-time tracking in gastrointestinal system in vivo are still major challenges in basic research and clinical applications. MATERIALS AND METHODS: In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Zhengzou, Jiang, Rong, Zhang, Lirong, Wu, Yunchao, Zhao, Xuefen, Zhao, Lulu, Li, Jiangang, Zou, Shengqiang, Zhang, Miaomiao, Du, Fengyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047607/
https://www.ncbi.nlm.nih.gov/pubmed/30034235
http://dx.doi.org/10.2147/IJN.S145837
Descripción
Sumario:INTRODUCTION: Although oral administration of Bifidobacterium is a promising approach for diseases, lack of resistance to harsh conditions and real-time tracking in gastrointestinal system in vivo are still major challenges in basic research and clinical applications. MATERIALS AND METHODS: In this study, we fabricated a chitosan-coated alginate microcapsule loaded with in situ synthesized barium sulfate (CA/BaSO(4) microcapsule) for oral Bifidobacterium delivery and real-time X-ray computed tomography (CT) imaging. CA/BaSO(4) microcapsules containing the Bifidobacterium were prepared in situ by one-step electrostatic spraying method, and then coated with chitosan. RESULTS: The results indicated that CA/BaSO(4) microcapsules with an average diameter of approximately 200 μm possessed favorable mechanical stability and X-ray attenuation capacity. Encapsulation of Bifidobacteria in the CA/BaSO(4) microcapsules exhibited superior resistance to cryopreservation and gastric acid environment in vitro. After oral administration in mice, these CA/BaSO(4) microcapsules could be real-time visualized by CT imaging and readily reached the intestine to release Bifidobacteria. CONCLUSION: The radiopaque CA/BaSO(4) microcapsules provide a novel platform for efficient protection, non-invasive real-time monitoring and intestinal-targeted Bifidobacterium delivery.